These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
136 related articles for article (PubMed ID: 12152160)
41. Suppression of non-small cell lung cancer proliferation and tumorigenicity by DENND2D. Ling B; Zheng H; Fu G; Yuan J; Shi T; Chen S; Liu Y; Liu Y; Cao Y; Zheng S; Guo S; Han N; Gao Y; Cheng S; Zhang K Lung Cancer; 2013 Feb; 79(2):104-10. PubMed ID: 23182661 [TBL] [Abstract][Full Text] [Related]
42. Isolation of a novel mouse variant of the drs tumor suppressor gene. Kawai T; Suzuki Y; Yamashita A; Inoue H Cancer Lett; 2002 Sep; 183(1):79-86. PubMed ID: 12049817 [TBL] [Abstract][Full Text] [Related]
43. Altered regulation of the cytochrome P4501A1 gene: novel inducer-independent gene expression in pulmonary carcinoma cell lines. McLemore TL; Adelberg S; Czerwinski M; Hubbard WC; Yu SJ; Storeng R; Wood TG; Hines RN; Boyd MR J Natl Cancer Inst; 1989 Dec; 81(23):1787-94. PubMed ID: 2555530 [TBL] [Abstract][Full Text] [Related]
44. Involvement of NANOG upregulation in malignant progression of human cells. Li Y; Higashiyama S; Shimakage M; Kawahara K; Yutsudo M; Watari A DNA Cell Biol; 2013 Mar; 32(3):104-10. PubMed ID: 23427894 [TBL] [Abstract][Full Text] [Related]
45. Reduced HIC-1 gene expression in non-small cell lung cancer and its clinical significance. Hayashi M; Tokuchi Y; Hashimoto T; Hayashi S; Nishida K; Ishikawa Y; Nakagawa K; Tsuchiya S; Okumura S; Tsuchiya E Anticancer Res; 2001; 21(1B):535-40. PubMed ID: 11299800 [TBL] [Abstract][Full Text] [Related]
46. Loss of the tumor suppressor PML in human cancers of multiple histologic origins. Gurrieri C; Capodieci P; Bernardi R; Scaglioni PP; Nafa K; Rush LJ; Verbel DA; Cordon-Cardo C; Pandolfi PP J Natl Cancer Inst; 2004 Feb; 96(4):269-79. PubMed ID: 14970276 [TBL] [Abstract][Full Text] [Related]
47. Immunoscreening of a cDNA library from a lung cancer cell line using autologous patient serum: Identification of XAGE-1b as a dominant antigen and its immunogenicity in lung adenocarcinoma. Ali Eldib AM; Ono T; Shimono M; Kaneko M; Nakagawa K; Tanaka R; Noguchi Y; Nakayama E Int J Cancer; 2004 Feb; 108(4):558-63. PubMed ID: 14696120 [TBL] [Abstract][Full Text] [Related]
48. Gene expression profiling of cultured human bronchial epithelial and lung carcinoma cells. Hellmann GM; Fields WR; Doolittle DJ Toxicol Sci; 2001 May; 61(1):154-63. PubMed ID: 11294986 [TBL] [Abstract][Full Text] [Related]
49. Expression of PFKFB3 and Ki67 in lung adenocarcinomas and targeting PFKFB3 as a therapeutic strategy. Li X; Liu J; Qian L; Ke H; Yao C; Tian W; Liu Y; Zhang J Mol Cell Biochem; 2018 Aug; 445(1-2):123-134. PubMed ID: 29327288 [TBL] [Abstract][Full Text] [Related]
50. Establishment and expression profiling of new lung cancer cell lines from Chinese smokers and lifetime never-smokers. Lam DC; Girard L; Suen WS; Chung LP; Tin VP; Lam WK; Minna JD; Wong MP J Thorac Oncol; 2006 Nov; 1(9):932-42. PubMed ID: 17409975 [TBL] [Abstract][Full Text] [Related]
51. [Quantitative analysis of thyroid transcription factor-1 mRNA expressions in primary lung cancer and its metastatic foci]. Bai XY; Shen H Nan Fang Yi Ke Da Xue Xue Bao; 2008 Jan; 28(1):20-5. PubMed ID: 18227018 [TBL] [Abstract][Full Text] [Related]
52. Clinical Significance of DNA Damage Response Factors and Chromosomal Instability in Primary Lung Adenocarcinoma. Okamoto T; Kohno M; Ito K; Takada K; Katsura M; Morodomi Y; Toyokawa G; Shoji F; Maehara Y Anticancer Res; 2017 Apr; 37(4):1729-1735. PubMed ID: 28373435 [TBL] [Abstract][Full Text] [Related]
53. CUEDC2 down-regulation is associated with tumor growth and poor prognosis in lung adenocarcinoma. Sun L; Bai L; Lin G; Wang R; Liu Y; Cai J; Guo Y; Zhu Z; Xie C Oncotarget; 2015 Aug; 6(24):20685-96. PubMed ID: 26023733 [TBL] [Abstract][Full Text] [Related]
54. [DNA chip analysis of gene expression patterns in poorly-differentiated human stage I lung adenocarcinoma]. Xing GH; Zhang JC Zhonghua Zhong Liu Za Zhi; 2004 Jan; 26(1):36-9. PubMed ID: 15059353 [TBL] [Abstract][Full Text] [Related]
56. The long non-coding RNA, GAS5, enhances gefitinib-induced cell death in innate EGFR tyrosine kinase inhibitor-resistant lung adenocarcinoma cells with wide-type EGFR via downregulation of the IGF-1R expression. Dong S; Qu X; Li W; Zhong X; Li P; Yang S; Chen X; Shao M; Zhang L J Hematol Oncol; 2015 Apr; 8():43. PubMed ID: 25925741 [TBL] [Abstract][Full Text] [Related]
57. [Northern blot analysis of nm23 gene expression in human lung cancer]. Liu L; Qin Y; Zhou Q Zhonghua Zhong Liu Za Zhi; 1998 Sep; 20(5):342-4. PubMed ID: 10921026 [TBL] [Abstract][Full Text] [Related]
58. [Expression and structure of BNIP3L in lung cancer]. Sun JL; He XS; Yu YH; Chen ZC Ai Zheng; 2004 Jan; 23(1):8-14. PubMed ID: 14720367 [TBL] [Abstract][Full Text] [Related]
59. Expression and significance of CD44s, CD44v6, and nm23 mRNA in human cancer. Liu YJ; Yan PS; Li J; Jia JF World J Gastroenterol; 2005 Nov; 11(42):6601-6. PubMed ID: 16425351 [TBL] [Abstract][Full Text] [Related]
60. Incidence of latent infection of Epstein-Barr virus in lung cancers--an analysis of EBER1 expression in lung cancers by in situ hybridization. Kasai K; Sato Y; Kameya T; Inoue H; Yoshimura H; Kon S; Kikuchi K J Pathol; 1994 Dec; 174(4):257-65. PubMed ID: 7884587 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]